TERRA MILLER: Open Payments
NPI 1174914907 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,063 in 79 payments from 24 companies in 2025. Trend: 2023 $2,234 · 2024 $2,494 · 2025 $2,063
Food & beverage: $2,063
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $396 |
| Amgen Inc. | 14 | $293 |
| Lilly USA, LLC | 8 | $243 |
| ABBVIE INC. | 5 | $216 |
| Novartis Pharmaceuticals Corporation | 14 | $199 |
| Otsuka America Pharmaceutical, Inc. | 1 | $122 |
| Sumitomo Pharma America, Inc. | 3 | $73 |
| Lundbeck LLC | 3 | $70 |
| Phathom Pharmaceuticals, Inc. | 2 | $57 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $54 |
Products named: LEQVIO, KISUNLA, REXULTI, BREZTRI, VRAYLAR, REPATHA, TEZSPIRE, OTEZLA.
Industry payments across AZ — which companies pay providers there.
